Siegfried Holding AG
SFZN
Rang in Aktien
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Aktienkurs
$88.34
Marktkapitalisierung
$3.87B
Veränderung (1 Tag)
1.68%
Veränderung (1 Jahr)
-12.97%
Land
CH
Handel Siegfried Holding AG (SFZN)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Siegfried Holding AG (SFZN)
Anzahl der ausstehenden Aktien zum October 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Siegfried Holding AG beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von October 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Siegfried Holding AG (SFZN) von 2002 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2025 | 43.76M | 1.54% |
| 2024 | 43.09M | 1.69% |
| 2023 | 42.38M | 0.40% |
| 2022 | 42.21M | 0.37% |
| 2021 | 42.05M | 1.45% |
| 2020 | 41.45M | 0.22% |
| 2019 | 41.36M | -0.67% |
| 2018 | 41.64M | 4.91% |
| 2017 | 39.69M | 2.15% |
| 2016 | 38.86M | -1.72% |
| 2015 | 39.54M | 2.20% |
| 2014 | 38.68M | -1.37% |
| 2013 | 39.22M | 8.27% |
| 2012 | 36.23M | -1.32% |
| 2011 | 36.71M | 8.64% |
| 2010 | 33.79M | 22.52% |
| 2009 | 27.58M | -0.49% |
| 2008 | 27.71M | 0.30% |
| 2007 | 27.63M | -0.21% |
| 2006 | 27.69M | 0.25% |
| 2005 | 27.62M | 1.23% |
| 2004 | 27.28M | 0.00% |
| 2003 | 27.28M | -0.13% |
| 2002 | 27.32M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
